Abstract
There are methodological difficulties in assessing cognitive function in narcolepsy, but despite these it appears that there is a defect in maintenance of attention, which is more significant than the problems with memory. The subject’s perception of memory loss is however greater than what can be demonstrated objectively. There may also be a generalised executive dysfunction unrelated to attention and memory deficits. Anxiety and depression are common, particularly in younger subjects. Psychosis is usually drug-induced, particularly by amphetamines. The realistic dreams and hypnagogic hallucinations should be distinguished from schizophrenia and REM sleep behaviour disorder.
There is considerable functional impairment due to the symptoms of narcolepsy with reduced quality of life, particularly in the domains of vitality and physical roles. Changes with age are probably important, but there are only few differences between the genders. Education, performance at work, social and recreational activities are all impaired by narcolepsy, but attention to lifestyle aspects and treatment with modern drugs, particularly modafinil and sodium oxybate, can improve functional capacity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schneider C, Fulda S, Schulz H. Daytime variation in performance and tiredness/sleepiness ratings in patients with insomnia, narcolepsy, sleep apnea and normal controls. J Sleep Res 2004;13:373–383
Hood B, Bruck D. Sleepiness and performance n narcolepsy. J Sleep Res 1996;5:128–134
Pollak CP, Wagner DR, Moline ML, et al. Cognitive and motor performance of narcoleptic and normal subjects living in temporal isolation. Sleep 1992;15:202–211
Valley V, Broughton R. Daytime performance deficits and physiological vigilance n untreated patients with narcolepsy-cataplexy compared with controls. Rev EEG Neurophysiol 1981;11:133–139
Schulz H, Wilde-Frenz J. The disturbance of cognitive processes in narcolepsy. J Sleep Res 1995;4:10–14
Rieger M, Mayer G, Gauggel S. Attention deficits in patients with narcolepsy. Sleep 2003;26:36–43
Naumann A, Bellebaum C, Daum I. Cognitive deficits in narcolepsy. J Sleep Res 2006;15:329–338
Godbout R, Montplaisir J. All-day performance variations in normal and narcoleptic subjects. Sleep 1986;9:200–204
Broughton RJ, Ghanem Q, Hishikawa Y, et al. Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls. Can J Neurol Sci 1981;8:299–304
Smith KM, Merritt SL, Cohen FL. Can we predict cognitive impairments in persons with narcolepsy? Loss Grief Care 1992;5:103–113
Aguirre M, Broughton R, Stuss D. Does memory impairment exist in narcolepsy-cataplexy? J Clin Exp Neuropsychol 1985;7:14–24
Rogers AE, Rosenberg RS. Tests of memory in narcoleptics. Sleep 1990;13:42–52
Henry GK, Satz P, Heilbronner RL. Evidence of a perceptual-encoding deficit in narcolepsy? Sleep 1993;16:123–127
Hood B, Bruck D. Metamemory in narcolepsy. J Sleep Res 1997;6:205–210
Fulda S, Schulz H. Cognitive dysfunction in sleep disorders. Sleep Med Rev 2001;5:423–445
Naumann A, Daum I. Narcolepsy: pathophysiology and neuropsychological changes. Behav Neurol 2003;14:89–98
Stores G. The protean manifestations of childhood narcolepsy and their misinterpretation. Dev Med Child Neurol 2006;48:307–310
Daniels E, King MA, Smith IE, Shneerson JM. Health-related quality of life in narcolepsy. J Sleep Res 2001;10:75–81
Dodel R, Peter H, Walbert T , Spottke A, Noelker C, Berger K, Siebert U, Oertel WH, Kesper K, Becker HF, Mayer G. The socioeconomic impact of narcolepsy. Sleep 2004;27:1123–1128
Stores G, Montgomery P, Wiggs L. The psychosocial problems of children with narcolepsy and those with excessive daytime sleepiness of uncertain origin. Pediatrics 2006;e1116–e1123
Shneerson JM, Myers AJ, Morrish E. Factors determining quality of life in narcolepsy. In preparation
Vourdas A, Shneerson JM, Gregory CA, Smith IE, King MA, Morrish E, McKenna PJ. Narcolepsy and psychopathology: is there an association? Sleep Med 2002;3:353–360
Fosse R, Stickgold R, Hobson JA. Emotional experience during rapid-eye-movement sleep in narcolepsy. Sleep 2002;25:724–730
Schenck CH, Mahwold MW. REM sleep behavior disorder: Clinical, developmental and neuroscience perspectives 16 years after its formal identification in sleep. Sleep 2002;25:120–138
Ervik S, Abdelnoor M, Heier MS, Ramberg M, Strand G. Health-related quality of life in narcolepsy. Acta Neurol Scand 2006;e114:198–204
Dodel R, Peter H, Spottke A, Noelker C, Althaus A, Siebert U, Walbert T, Kesper K, Becker HF, Mayer G. Health-related quality of life in patients with narcolepsy. Sleep Med 2007;8:733–741
Shneerson JM, Dauvilliers Y, Garcia-Borreguero D, Plazzi G. The impact of narcolepsy and its treatment – a European Study. Eur J of Neurol 2008 submitted for publication
Vignatelli L, D’Alessandro R, Mosconi P, Ferini-Strambi L, Guidolin L, De Vincentiis A, Plazzi G. Health-related quality of life in Italian patients with narcolepsy: the SF-36 health survey. Sleep Med 2004;5:467–475
Beusterien KM, Rogers AE, Walsleben JA, et al. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep 1999;6:757–765
Lamphere J, Young D, Roehrs T, et al. Fragmented sleep, daytime somnolence and age in narcolepsy. Clin Electroencephalogr 1989;20:49–54
Quinnell TQ, Smith IE, Shneerson JM. Impact of age on narcolepsy: evidence for an accelerated decline in nocturnal sleep quality. J Clin Sleep Med 2008 submitted for publication
Wittig R, Zorick F, Piccione P, Sicklesteel J, Roth T. Narcolepsy and disturbed nocturnal sleep. Clin Electroencephalogr 1983;14:130–134
Dauvilliers Y, Pennestri M-H, Petit D, Dang-Vu T, Lavigne G, Montplaisir J. Periodic leg movements during sleep and wakefulness in narcolepsy. J Sleep Res 2007;16:333–339
Billiard M, Besset A, Cadilhac J. The clinical and polygraphic development of narcolepsy. In: Guilleminault C, Lugaresi E, eds. Sleep/wake disorders: natural history, epidemiology, and long-term evolution. New York: Raven, 1983:171–185
Passouant P, Billiard M. The evolution of narcolepsy with age. In: Guilleminault C, Dement WC, Passouant P, eds. Narcolepsy. New York: Spectrum, 1976;176–196
Rosenthal LD, Merlotti L, Young DK, et al. Subjective and polysomnographic characteristics of patients diagnosed with narcolepsy. Gen Hosp Psychiatry 1990;191–197
Dauvilliers Y, Gosselin A, Paquet J, et al. Effect of age on MSLT results in patients with narcolepsy-cataplexy. Neurology 2004;61:46–50
Nevsimalova S, Vankova J, Pretl M, Bruck D. Narkolepsie v detsckem a adolescentnim veku-klinicke a psychosocialni aspekty. Ces a slov Neurol Neurochir 2002;3:169–174
Wise MS. Childhood narcolepsy. Neurology 1998;50:S37–S42
Goswami M. The influence of clinical symptoms on quality of life in patients with narcolepsy. Neurology 1998;50:S31–S36
Zwicker J, Bruck D, Parkes JD, et al. Acute mood improvement after amphetamine and methylphenidate in narcolepsy. J Sleep Res 1995;4:252–255
Schwartz JRL, Nelson MT, Schwartz ER, et al. Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness. Clin Neuropharmacol 2004;27:74–79
Shneerson J, Randall D, Cafferty F, et al. Treatment with modafinil may have beneficial effects on planning ability and mood in patients with excessive daytime sleepiness: findings from a pilot study. J Sleep Res 2006;15:P029
Saletu M, Anderer P, Semlitsch HV, et al. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy. Psychiatry Res 2007;154:69–84
Becker PM, Schwartz JRL, Feldman NT, Hughes RJ. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy. Psychopharmacology 2004;171:133–139
The Xyrem® International Study Group. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. J Clin Sleep Med 2005;1:391–397
The US Xyrem® Multicenter Study Group. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 2002;25:42–49
Weaver TE, Cuellar N. A randomized trail evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy. Sleep 2006;29:1189–1194
Hayduk R, Mitler A. Sodium oxybate therapy improves the quality of life of narcolepsy patients. Sleep 2001;24:A326
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Shneerson, J. (2010). Narcolepsy and Mental Health. In: Goswami, M., Pandi-Perumal, S., Thorpy, M. (eds) Narcolepsy. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0854-4_22
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0854-4_22
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0853-7
Online ISBN: 978-1-4419-0854-4
eBook Packages: MedicineMedicine (R0)